Similar articles

• Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analog.

  Lien EL, Fenichel RL, Grant NH, Boxill GC, Greenwood J, Yardley JP. Lien EL, et al. Metabolism. 1978 Sep;27(9 Suppl 1):1403-6. doi: 10.1016/0026-0495(78)90082-3. Metabolism. 1978. PMID: 683008 No abstract available.
• Metabolic effects of long-term somatostatin infusion in man.

  Gerich JE. Gerich JE. Metabolism. 1976 Nov;25(11 Suppl 1):1505-7. doi: 10.1016/s0026-0495(76)80179-5. Metabolism. 1976. PMID: 988466 No abstract available.
• The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.

  Ward FR, Leblanc H, Yen SS. Ward FR, et al. J Clin Endocrinol Metab. 1975 Sep;41(3):527-32. doi: 10.1210/jcem-41-3-527. J Clin Endocrinol Metab. 1975. PMID: 1159060
• Somatostatin (growth hormone-release inhibiting hormone).

  Gomez-Pan A, Hall R. Gomez-Pan A, et al. Clin Endocrinol Metab. 1977 Mar;6(1):181-200. doi: 10.1016/s0300-595x(77)80063-7. Clin Endocrinol Metab. 1977. PMID: 196795 Review. No abstract available.
• [Somatostatin--a hypothalamic factor inhibiting the secretion of growth hormone].

  Lankosz-Lauterbach J. Lankosz-Lauterbach J. Pediatr Pol. 1977 Aug;52(8):919-23. Pediatr Pol. 1977. PMID: 333364 Review. Polish. No abstract available.